# National Institute of General Medical Sciences

National Institute of General Medical Sciences is a Foundation based in Bethesda, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Bethesda, United States
- **Region:** North America
- **Address:** Bethesda, MD, United States
- **Assets under management:** Undisclosed
- **Website:** nigms.nih.gov

## Regulatory record

- **Reports private funds:** No

## About

The National Institute of General Medical Sciences (NIGMS) was established as part of the National Institutes of Health, with the specific mandate to support basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS allocates funds primarily through investigator-initiated research grants, training grants, and career development awards across multiple disciplines: molecular biology, genetics, cell biology, pharmacology, physiology, and computational biology. Notable funded programs include the Institutional Development Award (IDeA) program, which enhances research capacity in states with historically low NIH funding, and the Biomedical Technology Research Resources program, which develops cutting-edge tools and services. Geographic footprint is nationwide, with funded institutions in every state, though the institute's headquarters and administrative center is Bethesda, Maryland. As a federal agency, NIGMS does not disclose AUM in the traditional asset-management sense, but its fiscal year 2023 congressional appropriation was approximately $1.9B for extramural and intramural research programs. The institute employs roughly 130 full-time staff across its Bethesda campus. No separate philanthropic foundations or for-profit spinouts are documented. In November 2023, NIGMS launched the "Synthetic Biology for Environmental Sustainability" program to support research on engineering biological systems for climate and environmental applications. NIGMS operates as a research-funding agency rather than a direct investor or grant-making foundation with endowed capital. Its structural differentiator is its exclusive focus on fundamental discovery science, without the disease-specific mandates of other NIH institutes, and its allocation of ~75% of its budget to investigator-driven R01 grants, which are awarded competitively based on scientific merit.

## Sectors

- Health & Life Sciences
- Biotech & Pharmaceuticals
- Research & Development

## Questions

### How does NIGMS allocate its budget across research areas?

In fiscal year 2023, NIGMS allocated approximately $1.9B, with roughly 75% directed to investigator-initiated R01 research project grants, 10% to training and career development, and the remainder to research centers, infrastructure, and administrative support (per NIH public budget documents, 2023).

### What types of institutions receive NIGMS funding?

Recipients include universities, medical schools, hospitals, research institutes, and small businesses across all 50 states. The IDeA program specifically targets institutions in 25 states and Puerto Rico that historically receive lower levels of NIH support (per NIGMS official website).

### Does NIGMS fund research outside the United States?

NIGMS primarily funds domestic institutions, but it does support international collaborations through specific programs, such as the Fogarty International Center partnerships, which enable U.S.-led team research in low- and middle-income countries (per NIH policy documents).

### What is the difference between NIGMS and other NIH institutes?

Unlike disease-focused institutes like the National Cancer Institute or National Heart, Lung, and Blood Institute, NIGMS funds fundamental basic science that crosses all diseases and biological systems. Its mission is to “lay the foundation for advances in disease diagnosis, treatment, and prevention.”

### How does NIGMS evaluate grant applications?

Applications undergo peer review by a panel of scientific experts through the Center for Scientific Review. Reviewers assess scientific merit, innovation, investigator qualifications, and relevance to NIGMS's mission. Scores determine funding priority, with top-scoring applications funded until the budget is exhausted (per NIH grant review process).

## Related profiles

- [Jiangsu Yuguan](https://altss.com/profile/jiangsu-yuguan)
- [Advantage](https://altss.com/profile/advantage)

---

Source record modified: 2026-06-03T20:00:00.000Z

Last verified: not supplied by this public snapshot.

## Sources and provenance

- Organization website as recorded: https://nigms.nih.gov/
Source links do not imply that every field was verified on the page modification date. See [Altss methodology](https://altss.com/methodology).

Canonical page: https://altss.com/profile/the-national-institute-of-general-medical-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology